American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
2.
FullerMA, SajatovicM: Drug Information Handbook for Psychiatry: A Comprehensive Reference of Psychotropic, Non-psychotropic, and Herbal Agents, 6th ed. Hudson, OH: LexiComp; 2007.
3.
KimY-K, NaK-S, HwangJ-A, YoonH-K, LeeH-J, HahnS-W, LeeB-H, JungH-Y: High IGF-1 in patients with bipolar I Disorder: A trait marker?. J Affect Disord, 151:738-743, 2013.
4.
LiX, ZhangT, HeS, HongB, ChenZ, PengD, WuY, WenH, LinZ, FangY, JiangK: Elevated serum levels of FGF-2, NGF and IGF-1 in patients with manic episode of bipolar disorder. Psychiatry Res, 218:54–60, 2014.
5.
NaranjoCA, BustoU, SellersEM, SandorP, RuizI, RobertsEA, JanecekE, DomecqC, GreenblattDJ: A reliable method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther, 30:239–245, 1981.
6.
RogolAD, HaydenGF: Etiologies and early diagnosis of short stature and growth failure in children and adolescents. J Pediatr, 164Suppl 5:S1–S14, 2014.
